Description: Changzhou Qianhong Biopharma CO.,LTD engages in the research and development, production, and sale of bio-pharmaceutical products with a focus on polysaccharides and enzymes in China. The company provides various API products, including heparin sodium, heparin calcium, enoxaparin sodium, nadroparin calcium, and dalteparin sodium for use as anticoagulants; pancreatin for use as a digestive agent; asparaginase for use as an antineoplastic agent; kallidinogenase kallikrein for use in the treatment of microcirculation disorders; and heparinoid. It also offers a range of preparations, such as nadroparin calcium PFS, enoxaparin sodium PFS, dalteparin sodium PFS, and asparaginase and heparin sodium injections for use as anticoagulants. In addition, the company exports its products. Changzhou Qianhong Biopharma CO.,LTD was founded in 1971 and is headquartered in Changzhou, China.
Home Page: www.qhsh.com.cn
No. 90 Changjiang Middle Road
Changzhou,
213022
China
Phone:
86 519 8515 6003
Officers
| Name | Title |
|---|---|
| Ms. Aiqun Xiao | Financial Director |
| Mr. Xiang Zhou | Deputy GM & Non-Independent Director |
| Mr. Lijun Wei | Chief Engineer |
| Mr. Yi Yao | Board Sec. |
| Ms. Yong Fan | Audit Director |
Exchange: SHE
Country: CN
Currency: Renminbi (¥)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 30.0952 |
| Price-to-Book MRQ: | 4.2196 |
| Price-to-Sales TTM: | 4.6729 |
| IPO Date: | 2011-02-18 |
| Fiscal Year End: | December |
| Full Time Employees: | 1151 |